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THE Proceedings of the First National Conference on Cardiovascular Diseases in 1950 
include a brief review of epidemiology. In referring specifically to the ‘degenerative’ 
cardiovascular diseases, LANGMUIR [l] stated : “ . . . epidemiology has contributed 
little other than to help in defining the problem, and to assist in planning facilities to 
meet it.” Viewed against this blunt and fair appraisal of the situation at the time, 
knowledge of the epidemiology of coronary heart disease has, indeed, made remarkable 
strides in the 15 relatively short years that have since passed. In fact, looking over the 
history of medicine, few fields seem to have made such rapid progress over so brief a 
span of time. As a result, DAWBER and KANNEL [2], referring to coronary disease, 
have rightly stated : “It has seldom been possible in noninfectious diseases to identify 
. . . highly susceptible individuals years before the development of disease.” When 
new fields of research come into their own with such sudden force, the time is usually 
ripe for several reasons and no isolated influence can be singled out to account for the 
phenomenon. Concerning the epidemiology of coronary heart disease, however, 
reference must be made to the intellectual, apart from the financial stimulus which 
came from the National Heart Institute, illustrated by Dr. JAMES WATT in an address 
on “Arteriosclerosis and Epidemiology”, presented before the American Society for 
the Study of Arteriosclerosis in 1953 [3]. Another landmark was the “Conference on 
Epidemiology of Atherosclerosis and Hypertension”, at Arden House in 1956, under 
the auspices of the American Heart Association and the National Heart Institute [PI. 
These two agencies again took the lead in sponsoring, in 1959, the conference on 
“Epidemiology of Cardiovascular Disease Methodology” in Princeton [5]. Con- 
currently, the World Health Organization set up a division of Cardiovascular Diseases 
which has made a number of important contributions to the field of epidemiology 
[6-81. Other national and international groups, not to mention individual leaders, 
have played decisive roles in these developments but it is the purpose of this review to 
summarize the achievements rather than the organization of epidemiological research 
in coronary heart disease. Nevertheless, it seemed appropriate to mention at least 
some of these undercurrents since epidemiological investigations especially call for 
collaborative efforts and interchanges concerning research organization and design [9]. 
This review will be confined to the epidemiological features of coronary heart 
disease as they present themselves in studies among human population groups. Other 
reviews have appeared in recent years [lo-221. Epidemiology is more properly 
regarded as a field of activity which embraces, in addition, clinical and laboratory 
investigations as they tie into population studies [ 151. These aspects will, however, be 
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considered elsewhere as part of the National Conference so that a more narrow 
definition of epidemiology will be used for the purpose of this review. The literature 
in this field has grown to such proportions that it will be impossible to be comprehen- 
sive and include all references or to discuss all facets of the problem. Some relevant 
and important contributions will be missed while others are being quoted to illustrate 
the issue rather than to provide an exhaustive documentation. 
MORTALITY STATISTICS 
The recent advances in coronary heart disease epidemiology are largely due to the 
fact that field studies among living populations have gained ascendance over inform- 
ation from mortality statistics (sometimes euphemistically called ‘vital’ statistics) 
which had, for many years, been the only source of information on the distribution of 
this disease. Nevertheless, mortality statistics remain one important area of research 
and yield data which cannot be obtained in any other way. At the same time, great 
efforts are being made to improve the accuracy of diagnoses on death certificates 
[23, 241; a recent careful study has revealed that an entry of ‘arteriosclerotic heart 
disease’ in a sample of certificates from the United States is often poorly substantiated 
[25]. Similarly, a considerable proportion of such entries is based on unattended 
deaths without autopsy confirmation [26]. In spite of these problems, it is rewarding 
to review the data, providing their limitations are kept in mind. 
United States 
Beyond middle-age, the mortality trend from cardiovascular-renal diseases has 
remained steady or decreased somewhat over the past decades [27]. Mortality from 
arteriosclerotic heart disease, by contrast, has increased [21, 201 and it is likely that 
this increase is largely real [21]. In fact, the view that coronary heart disease is due, to 
a considerable degree, to environmental influences is based in part on this observation. 
Between 1950 and 1960, however, deaths from this disease have increased at a lesser 
rate, amounting to 4.3 per cent over this period for white men aged 45-64 years [28]. 
It is reassuring that the increase has been less in recent years but this is no ground for 
gratification since the death rate from this disease in 1950 was already so high that it 
is hard to conceive how it could have increased much further. Indeed, it is rather sur- 
prising that such importance has been given to the fact that the total death rate from 
all cardiovascular-renal diseases in middle-aged men has decreased some 6 per cent 
between 1950 and 1960, suggesting that the tide has turned [28]. That this view is 
premature may be demonstrated by taking the population of white men, aged 45-64 
in 1950, as the denominator and applying to it the death rates obtained from several 
sources [29, 301, in the relevant categories in 1950 and 1960 (Table 1). In this way, the 
actual number of deaths in 1950 may be compared with the numbers which would have 
been expected if the 1960 rates had prevailed in 1950. It will be seen that 7228 fewer 
deaths from the major cardiovascular-renal diseases would have occurred in 1950 if the 
1960 rates had applied. At the same time, it is apparent that the increase in deaths 
from arteriosclerotic heart disease is about balanced by a decrease in deaths from 
hypertensive disease and vascular lesions affecting the central nervous system. Thus, 
there is no real change in the total frequency of deaths from the consequences of 
arteriosclerosis and hypertension; the overall decrease for the major cardiovascular- 
renal diseases is accounted for by a decline in deaths from other types of cardiovascular- 
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TABLE 1. DEATHS AND DEATH RATES FROM VARIOUS FORMS OF CARDIOVASCULAR DISEASES AMOKG 
WHITEMENAGED~~-@INTHE UNITED STATES: COMPARISONBETWEENOBSERVED DEATHSIN~~SOAND 
DEATHS WHICH WOULD HAVE BEEN EXPECTED IN 1950IF THE RATES PREVAILING IN 1960 HAD APPLIED 
Category 
Death rate Number of deaths Difference 
Age Population per 100,000 in : in 1950 between 
observed 
in 1950 1950 1960 Observed Expected and ex- 
pected nos. 
Major cardio- 45-54 7,836,299 508.1 477.5 39,815 37,418 
vascular-renal 55-64 6,180,287 1337.3 1258.5 82,648 77,790 
diseases 45-64 122,463 115,208 -7255 
Arteriosclerotic 45-54 7,836,299 323.1 352.5 25,311 27,623 
heart disease 55-64 6,180,287 812.9 901.3 50,238 55,703 
45-64 75,555 83,326 +7771 
Hypertensive 45-54 7,836,299 33.8 14.9 2,651 1,168 
heart disease 55-64 6,180,287 105.8 52.3 6,540 3,232 
45-64 9,191 4,400 -4791 
Vascular lesions 45-54 7,836,299 53.7 40.9 4,208 3,205 
affecting CNS 55-64 6,180,287 182.2 139.0 11,260 8,591 
45-64 15,468 11,796 -3672 
renal diseases. Also, in terms of numbers rather than rates the lives saved are, indeed, 
few among these particular men. This is particularly relevant if it is recalled that no 
less than one-third of all deaths among white men in the United States between the 
ages of 1 and 65 are due to arteriosclerotic heart disease. It is concluded that, in terms 
of mortality, no gains in the control of coronary heart disease have been made since 
1950. This actually would not have been expected since there has been no large-scale 
effort to control the factors which are thought to predispose to this disease. 
In contrast to the national picture, death rates from arteriosclerotic heart disease in 
California among white men have declined slightly in the 1950’s; among Negro men, 
however, the corresponding rates have risen quite steeply 1311. National data have 
likewise shown that the rise in death rates from arteriosclerotic heart disease has been 
more marked among non-white men [30]. This important epidemiological finding 
calls for a detailed comparison of rates in various states or regions. Death rates from 
other causes are also high among Negroes [32]. The increase in arteriosclerotic heart 
disease mortality has been greatest in states where the rates were initially lowest, 
especially in the South [26] ; the possibility that this pattern in is part accounted for by 
changing fashions of death certification must be kept in mind and would particularly 
apply to the Negro population. 
Deaths from the major cardiovascular-renal diseases in the country as a whole have 
declined for women as well as for men [27]. Those from arteriosclerotic heart disease, 
however, have risen in women, as in men, in both the non-white and white groups [30]. 
Since the rates in women are lower than in men, the numbers on which some of these 
changes in rates are based are relatively small so that slight variations over time on the 
mode of death certification could affect these rates appreciably. The trend of mortality 
among women over the next decade will be followed with great interest, especially 
among non-white women who show higher arteriosclerotic heart disease rates than 
white women aged up to 75 years [33]. 
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Variations in arteriosclerotic heart disease mortality between the various states 
continue to be intriguing and unexplained. There can be little doubt that the observed 
differences are, at least in part, real [34]. While rates are higher in metropolitan than 
non-metropolitan areas, these trends are not entirely accounted for by differences in 
urbanization, though variations within the State of New York seem to be associated 
with an urban-rural gradient [35-371. Preliminary observations suggest that persons 
born in ‘high mortality’ states carry with them a high mortality from arteriosclerotic 
heart disease even when they die in a ‘low-mortality’ state, and vice versa [38]. If 
confirmed, these data would provide a striking demonstration of the importance of 
influences in early life on the later development of chronic disease. 
On the basis of mortality data, areas of high and low risk within the United States 
have been identified [38]. Field studies in these areas are being instituted, in order to 
verify these differences and discover their causes [39]. 
International trends and comparisons 
It has been recognized for many years that the mortality from the arteriosclerotic 
diseases varies from country to country [40]. The need to buttress these suggestions 
with data from field studies was recognized with particular clarity and put into action 
by KEYS [41]. It is hard to believe that the striking gradients for arteriosclerotic heart 
disease mortality are largely due to differing fashions in death certification. Existing 
data have been well summarized in several publications [13, 42, 431. 
As a general rule, the rates are greater in countries with higher living standards. 
Yet, several countries with high socio-economic status and advanced levels of medical 
care differ strikingly in arteriosclerotic heart disease mortality. Thus, the United States, 
Canada and Australia have much higher rates than the Netherlands, Sweden or Swit- 
zerland. It is entirely possible that differences in mortality in such situations merely 
indicate that the disease is as frequent but less lethal in such countries. More will be 
learned from refined studies among sub-groups than from national averages. Data on 
mortality serve a useful purpose by pinpointing areas in which field studies among 
living populations may advantageously be done. 
Has coronary heart disease become more frequent in other countries, as appears to 
be the case in the United States? Such trends have been carefully analyzed for the 
British Isles and the consensus seems to be that the increase is largely real [44,45]. An 
interesting dissent is based on calculations intended to show that this increase can be 
accounted for by the survival of persons who would have otherwise died earlier in life 
from other diseases, especially infections [46, 471. It would be true that persons prone 
to, say, tuberculosis would also be preferentially prone to coronary heart disease. It 
is not impossible that such general rather than specific proneness to disease exists; 
thus, States of the Union which have higher rates for arteriosclerotic heart disease have 
also, in general, higher rates for other causes [34]. For the time being, such speculations 
must remain interesting hypotheses. 
In countries other than the United States, regional differences in mortality within 
the same country have also been reported. Mortality is higher in Eastern than Western 
Finland [48]. Similarly, rates are higher in some parts of the Irish Republic than in 
others [49]. These differences, as in Finland, may be partly due to diet [48]. Hardness 
of water has also been correlated with regional differences and will be discussed later. 
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EPIDEMIOLOGICAL PATHOLOGY 
Clinical methods are notoriously insensitive in detecting the early stages of coronary 
heart disease and even the advanced stages are frequently unaccompanied by symptoms 
or electrocardiographic signs. These shortcomings put limitations on the inferences 
which can be drawn from epidemiological data based on clinical evidence. Examina- 
tion of pathological specimens, on the other hand, yields a quantitative spectrum of the 
lesions in both the coronary arteries and the myocardium by stages of severity. Not all 
the technical problems of quantitation, either in terms of gross or microscopic appear- 
ance or injection techniques, have been overcome and the problems in inter- and 
intra-observer variation remain troublesome; nevertheless, considerable progress has 
been made toward refining and standardizing the methods of pathological assessment 
[50, 511. As a result, epidemiological information based on pathological studies is 
becoming increasingly valuable. Such data are subject to the bias inherent in autopsy 
material; yet, this type of knowledge cannot be obtained in any other way. As long as 
the potential methodological and statistical pitfalls are kept in mind, epidemiological 
pathology will make an increasingly important contribution to the field. 
United States 
From the paramount point of view of prevention, it is critical to know to what 
extent coronary atherosclerosis exists among young persons. These lesions, except in 
the more advanced stages, may be partially reversible or, at least, subject to arrest [52] 
but the nature of the process is such that eventual disease control must aim at 
preventing significant lesions from developing. The problem was brought into focus 
by a report on young United States soldiers killed in action; 15.3 per cent of these 
men evidenced plaques in the coronary arteries occluding half or more of the lumen 
[53]. Similarly, in a study in New Orleans, the prevalence of coronary fibrous plaques 
was 17 per cent and 45 per cent in white males aged lo-19 and 20-29 years, respec- 
tively; the prevalence among females and Negroes of either sex was considerably 
lower at these ages [54]. In terms of surface involvement by fibrous plaques in the 
anterior left descending branch of the coronary artery, the area covered was 6.8 per 
cent in the 20-29 year old group and 22.2 per cent in the 30-39 year old group among 
white males in New Orleans [55]; since these lesions are focal by nature an area 
involvement of this degree is, indeed, extensive. 
Several large-scale autopsy studies providing information on coronary and myo- 
cardial disease have been published in the United States [56-601. In one series, 
representing a very high necropsy rate among all deaths in a community of 30,000, 
25-100 per cent atherosclerotic obstruction was noted in 74 per cent of autopsies on 
adults [60]. In any case, no one doubts the seriousness and extent of the problem in 
the United States. The need is for studies which will cast light on the factors which are 
responsible for this situation. Such studies include those in which an attempt is made 
to relate long-term living habits and events immediately preceding death to autopsy 
findings; some of these are in progress [24]. 
Other countries 
Extensive investigations, comparing autopsy material from different countries by 
standardized methods, are in progress on the American continent [61]; preliminary 
data suggest the existence of marked differences [55]. Other groups are comparing the 
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geographic pathology of coronary and aortic lesions in the United States and Africa, 
collecting simultaneous information on the fat content of tissues [62, 631. There is a 
suggestion that the extent of coronary disease may vary quite strikingly even though 
aortic involvement shows little difference [64, 651. The World Health Organization is 
taking an active lead in these international endeavors [66]. 
These studies aim largely at the demonstration and elucidation of overall differences 
between populations varying in overall living standards; of equal importance are those 
which compare groups within the same country. Where marked social gradients 
within the same population exist, similar gradients in the extent of atherosclerosis 
should be looked for; this has been done but representative autopsy material by social 
class is clearly difficult to obtain, particularly in countries of special interest for this 
purpose [67-701. Some investigators have stressed the ubiquitous nature of athero- 
sclerosis which would, by implication, belittle the importance of any such differences 
[71]. Confirmation of these views must await the use of truly comparable methods of 
assessment of lesions; it is entirely possible that, in some populations, social class 
gradients in themselves do not mirror the frequency of coronary atherosclerosis. The 
problem does not revolve around the question whether lesions are present or absent 
since, in this sense, atherosclerosis is indeed ubiquitous, but on whether their distribu- 
tion differs in degree from population to population. 
British studies are of particular interest and have been stimulated no doubt in part 
by a distinct tendency among workers in that country to attribute the arterial lesion 
predominantly to a defect in blood clotting mechanisms or to the related view that the 
epidemiology of the acute and supposedly thrombotic event may differ from the 
epidemiology of the slowly developing, underlying lesion [74]. A detailed discus- 
sion of this issue is beyond the scope of this review but it is worth stating, without 
further comment, that it is the exception rather than the rule for men who died of 
acute heart attacks to show evidence of recent thrombosis [57,75]. Even in the series 
of CRAWFORD and his colleagues who adhere to the thrombotic theory, only half of 
these cases showed a recent thrombus; it must be admitted that this does not negate 
the theory which implies that even the non-occluding lesion is basically thrombotic 
[76]. MITCHELL and SCHWARTZ find that very recent infarcts invariably show throm- 
botic occlusion [77]. The field is in great need of further study by methods which can 
be applied to living populations as part of epidemiological surveys. 
British data have suggested an inverse relation between myocardial scars (but not 
coronary atherosclerosis) and physical activity, pointing toward the importance of the 
collateral circulation and the need to investigate the myocardial as well as the arterial 
components of the heart [78]. Coronary atherosclerosis, as seen by the pathologist, 
appears to occur as commonly among British as among American young men [79]. 
PREVALENCE AND INCIDENCE 
Knowledge of the frequency of coronary heart disease in different populations and 
population segments must necessarily be based on surveys among living people. In 
view of the fact that such surveys are generally difficult and costly in effort and funds, 
it is all the more remarkable how many such studies are now in progress. The aim is 
two-fold: to determine the presence of disease and to measure the predisposing and 
associated factors in the population under study. Knowledge of either of these two 
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sets of data is important but clues on causation can only come from obtaining both 
simultaneously in the same persons. 
Methods to determine the frequency of disease, and particularly the earliest signs of 
disease, are still inadequate. Nevertheless, the limit of usefulness in epidemiological 
studies of the time-honored clinical indices of angina pectoris, myocardial infarction 
and electrocardiographic changes has by no means been reached. The use of mutually 
acceptable, minimal criteria for categorizing the data and comparable methods for 
their collection should aid materially in establishing and interpreting meaningful 
trends and differences between people and groups. Much effort has been spent toward 
these ends [5, 9, 80-841. At the same time, the use of more rational and sensitive 
electrocardiographic lead systems and such aids as roentgenographic visualization of 
coronary calcifications by newer techniques or estimation of myocardial contractility 
could contribute materially in defining the borderlands between health and disease 
[85-911. 
Methods to assess risk are also in need of refinement. Progress has been made in 
standardizing lipid determinations and blood pressure measurements [92-941. 
Methods of dietary evaluation and the quantitation of physical activity represent other 
epidemiological tools which require elaboration [5, 95, 961. Biochemical, serological 
and physiological methods applicable in field studies will, no doubt, yield data on risk 
factors not hitherto identified. The study of reaction to emotional stimuli is an area 
to which increasing attention is being given [97]. 
With the advent of electronic computers, the whole field of data analysis has been 
simplified in many ways. Statistical computations which would have been out of 
practical reach can now be done with relative ease and speed [98, 991. 
The recording of physiological data, such as electrocardiograms, on tape, not only 
reduces observer error and variation but saves much time [IOO, 1011. 
In epidemiological studies where very large numbers of data have to be analyzed and 
correlated, the availability of these procedures opens up new possibilities. It is a 
mistake to think that these developments will replace human thought and ingenuity; 
on the contrary, they demand especially high levels of these qualities. 
United States 
Prevalence rates are less telling than incidence rates because they necessarily apply 
only to survivors and because they are more sensitive to selective factors in the defini- 
tion of the study population than a cohort identified for prospective studies of new 
disease incidence. However, prevalence studies are easier, covering as they do a 
shorter space of time, and yield valuable data as long as their limitations are kept in 
mind. Prevalence rates for coronary heart disease in men, based on several studies in 
the United States, are summarized in Fig. la; references are given in the legend 
[102-1101. Prevalence rises with age, as expected, but striking differences from 
study to study are seen within each decade. Some of these differences are likely to be 
real but others are probably due, at least in part, to differences in diagnostic definition. 
The need for comparable methods and criteria in these investigations is well illustrated 
by these data. As a rough approximation, prevalence rates in the fifth decade (age 
40-50) are around 2-3 per cent, rising to about 4-5 per cent in the sixth decade. The 
relatively high rates shown for the Tecumseh study are shown purposely since they are 
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FIG. la. Prevalence rates for coronary heart disease among men (per 1000) 
1. Framingham, Mass. [102] 
2. Albany, N.Y. [103] 
3. Los Angeles [104] 
4. Pittsburgh [105] 
5. New York (Italian) [106] 
6. New York (Jewish) [106] 
7. Chicago (STAMLER) [107] 
8. Chicago (PAUL) [108] 
9. Evans Co., Ga. (White) [109] 
10. Evans Co., Ga. (Negro) [109] 
11. Tecumseh, Michigan [I lo] 
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based deliberately on the inclusion of men who show frank inversion of T-waves over 
the left chest and corresponding limb leads in the absence of left ventricular hyper- 
trophy [l lo]. While such T-wave changes do not signify, unlike abnormal Q-waves, 
past evidence of myocardial infarction, it is likely that they are indicative, at least in a 
country like the United States, of coronary heart disease in the vast majority of 
instances, after exlcuding other forms of heart disease which was done in this case. It 
is likely that the use of stricter criteria underestimates the prevalence of detectable 
disease in such a population though more rigid criteria have the advantage of affording 
a greater degree of certainty. Several studies have shown that the prognostic signifi- 
cance of so-called non-specific T and S-T wave changes indicates a preferential risk 
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FIG. lb. Prevalence rates for coronary heart disease among women (per 1000) 
9. Evans Co., Ga. (White) [109] 
10. Evans Co., Ga. (Negro) [109] 
11. Tecumseh, Michigan [l lo] 
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It is beyond the scope of this review to discuss these data in detail but close scrutiny 
reveals interesting similarities and differences, as does a comparison of the rates in men 
and women (Fig. lb). No attempt had hitherto been made to present available data on 
prevalence in this fashion and the summary, as given, is of value in estimating the 
burden of this disease in the population and in the design of new epidemiological 
studies in different population segments. A comprehensive account of the prevalence 
of coronary and other forms of heart disease, based on clinical examinations in a 
random sample of the population of the United States was recently published as 
part of the National Health Survey [I 141; the reported rates for coronary heart 
disease are generally within the range shown in Fig. 1. 
Other data on prevalence are available, but are less readily summarized because of 
differences in sampling, study design or methods [I l-117]. These and others have 
been reviewed [118, 1191. Other data are based on surveys using questionnaires 
without physical examinations [120]; such information is important for the delineation 
of medical care problems relating to coronary disease but does not lend itself easily to 
epidemiological inferences on etiology. Correlations between information of this type 
and data based on clinical examinations have been made [121, 1221. 
Prevalence studies among special population groups within the United States have 
been of considerable interest. Low rates as found among the Navajo Indians, the low 
rates as inferred from mortality data among Seventh-Day Adventists and the lower 
rates among Italian as compared with Jewish clothing workers in New York are cited 
[106, 123, 1241. Studies, to be extended longitudinally among monks belonging to 
different orders, will also aid in identifying the factors which account for these 
differentials [ 1251. 
Incidence rates from several studies are summarized in Figs. 2a and 2b; references 
are given in the legend [103, 104, 107, 108, 126-1321. Considerable variations may 
again be noted among different investigations at given age ranges. In middle age, an 
average estimate suggests a yearly incidence rate of approximately 1 per cent among 
men and, perhaps, 0.2 per cent among women in the United States. Earlier remarks 
with regard to diagnostic criteria and methods apply here with equal force. Moreover, 
even though most of these rates are based on observations among adequate numbers 
of men and women, the standard error of each rate is considerable and some 
apparent differences may not be statistically significant, as has been pointed out 11331. 
International comparisons 
Even though a considerable number of prevalence surveys have been conducted in 
recent years in various parts of the world, differences in population sampling and 
methodology make it difficult to compare these rates. Thus, the likelihood that 
marked geographic variations exist still rests largely on mortality statistics. Data 
based on the proportion of cases of myocardial infarction among hospital patients are 
difficult to interpret from an epidemiological point of view, though they do provide 
suggestive leads. 
Two British surveys have yielded very high prevalence rates (24-38 per cent)among 
men aged 55-64 years [134, 1351. The prevalence was also high in a group of old men 
in Ireland [ 1361; the prevalence of definite coronary disease among these men, who 
were 65-85 years old, was 20 per cent while men in their 60’s ,in a study in Birmingham, 
showed a rate of 8.4 per cent [137]. Among men and women mostly in their 70’s, 
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FIG. 2a. Incidence rates for coronary heart disease among men (per 1000 per year) 
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FIG. 2b. Incidence rates for coronary heart disease among women (per 1000 per year) 
1. Framingham, Mass. [126] 
5. DuPont employees [127]-acute myocardial infarction only. 
angina was present among 6.5 per cent [138]. In a study of telephone workers in 
Britain and the United States, using identical methods, angina was of similar frequency 
but myocardial infarction was less common in Britain [139]. It is clearly not possible, 
at this time, to give a definitive estimate of coronary disease prevalence in different 
groups in Britain. The rates certainly do not appear to be markedly lower than in the 
United States. Thus, in a representative sample of post office van drivers in Britain, 
deep and wide Q-waves alone were seen in the electrocardiograms of about 2-3 per 
cent of men aged 40-64 years [140]. 
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Using comparable electrocardiographic criteria according to the ‘Minnesota Code’ 
[80], the latter rate, as found in Britain, may be contrasted with a rate of 1 per cent 
among Finnish men, aged 20-59 years [141]. In view of the high sensitivity of these 
rates to age, no fine comparison is possible at this point. The overall prevalence rate 
among Finnish men in their 40’s and 50’s was 5.9 per cent and 9 per cent, respectively, 
quite comparable with the rate in the United States where mortality is similar to 
Finland, whereas mortality from arteriosclertoic heart disease in Britain is appreciably 
lower than in either of these other two countries. 
Several prevalence studies are in progress in other European countries, such as 
Switzerland [142], Czechoslovakia [143] and those which are part of the co-operative 
group under the chairmanship of KEYS [144] in Italy, Greece, Finland, Yugoslavia, 
the Netherlands, as well as in the United States; incidence rates will also be obtained 
in these surveys. Existing data on the incidence of coronary heart disease in Europe 
are scanty. The rates obtained by MORRIS and his colleagues [ 1311 among London 
Transport Workers are shown in Fig. 2a; these rates are not out of line with those in 
the United States. Similarly, preliminary data from a town in Holland [132] suggest 
similar rates in this community and Framingham, Massachusetts. It is possible, 
therefore, that mortality does not mirror morbidity and that men with coronary disease 
in Britain and the Netherlands are less likely to die early from the disease; further 
data are clearly needed. Incidence rates in MalmG, Sweden, are likewise similar to 
rates in the United States [145, 1461. 
Epidemiological data relating to coronary heart disease and factors predisposing to 
it from different parts of the world are so abundant that it would be impossible to 
summarize them adequately except in a lengthy review devoted to this subject alone. It 
is, perhaps, surprising that no such comprehensive review has been written though 
several authors have provided partial outlines [ 14, 15, 147-1491; the complexity of the 
field is evident. However, the data accumulation and methodological improvements 
are so rapid that a major review effort would be unrewarding since it becomes so 
quickly outdated. Populations in which important data have been collected are among 
white, Bantu and other racial groups [150-1611 in Africa, the various ethnic sub- 
divisions in Israel [162-1691, groups in India [170-1781, Japan [179-1831, China 
[184, 1851, the Pacific area [186-1921 and in South and Central America [193-1971. 
It seems fair to conclude from these studies that, in general, the frequency of coronary 
heart disease is greater among the groups with higher socio-economic standards, 
though there may be epidemiologically important exceptions to this rule which 
demand further study [70]. This conclusion has little meaning in itself unless the 
factors related to these gradients can be identified. Those which are most obviously 
under suspicion are diet, serum cholesterol levels, physical activity and smoking; 
blood pressure distributions in some of these low-risk groups are not infrequently 
similar to those in Western countries [198] so that high blood pressure level in itself is 
not likely to be among the most critical factors underlying the majority of these 
populations differences. These risk factors will be discussed shortly. 
Differences within Japan, comparing rates which seem to be lower in Nagasaki than 
Hiroshima [199], are likewise intriguing, as is the observation of lower rates in Hiro- 
shima as compared with Framingham, Massachusetts [200]. Preliminary data suggest- 
ing that some manifestations of coronary disease in two populations of low [197] or 
relatively low [194] socio-economic status in Jamaica and Chile, respectively, may be 
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similar to the rates in the United States is very challenging. Particular attention should 
be paid to data on predisposing factors among young people in these populations 
since data from Guatemala suggest that serum cholesterol levels show a social class 
gradient early in life [201]. Further knowledge is likely to come from intensive studies 
in well-defined groups rather than from broad and more supeficial surveys; examples 
are the studies among the Maoris who seem to be especially predisposed and the 
Yemenite Jews who are also in rapid transition from a more primitive to a more 
‘Westernized’ mode of life. Prospective data from such investigations are awaited 
with much anticipation. Epidemiological and dietary studies among populations who 
show little atherosclerosis have been recently reviewed [202]. 
RISK FACTORS 
An attribute which appears to occur more commonly among persons with coronary 
heart disease than control subjects is defined, for the purpose of this discussion, as a 
‘risk factor.’ It is implied in this particular definition that an association between the 
disease and a risk factor is not necessarily causal; proof of causality in epidemiological 
research is a complicated subject [203]. Strictly speaking, one should only use the term 
‘risk factor’ if such proof has been obtained but a less rigorous definition serves the 
current needs, remembering that there are different levels of certainty as regards 
‘proof.’ From the public health point of view, the question is how much certainty is 
required before action is taken. It is fair to say that much has been learned regarding 
risk factors in coronary heart disease, if ‘risk factor’ is defined as stated. 
Serum cholesterol and blood pressure levels 
Most workers in the field would probably agree that, among all the risk factors 
studied, the relationship between serum cholesterol and blood pressure levels and 
coronary heart disease is established most securely. Of the two, the relationship to 
serum cholesterol levels is somewhat more controversial. However, an association 
between coronary disease and serum cholesterol levels has been demonstrated in most 
epidemiological studies. These associations are less apparent in some studies than in 
others, such as those among a random sample of men in Wales [83] and those among 
clothing workers of Jewish origin in New York City [204]. In these two studies, an 
association between serum cholesterol levels, though slight, is nevertheless present. 
It is entirely conceivable that, in some groups, factors other than those related to the 
determinants of serum cholesterol levels are likely to be more dominant than in others. 
The evidence linking serum cholesterol levels and atherosclerosis is not, of course, 
based on epidemiological data alone but is in keeping with clinical and experimental 
observations. Moreover, it is supported by circumstantial evidence from epidemio- 
logical studies in various countries since mortality and, as far as it has been adequately 
measured, morbidity from coronary disease tend to be related to the ‘average’ serum 
cholesterol level in these populations [205, 2061. In countries with a lower disease 
frequency, patients with coronary disease tend to have higher levels than the popula- 
tion average [207] and appear to develop the disease generally at lower serum choles- 
terol levels than would be the case in, say, the United States; it must be remembered 
that myocardial infarction does, indeed, occur among persons with relatively low 
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KEYS and BLACKBURN [22, 2081 believe that there is an exponential relationship 
between cholesterol level and coronary disease. 
The most valid data are those which are based on one-time or, preferably, prospec- 
tive studies among representative population groups. Some of these are summarized 
in Table 2. It may, perhaps, come as a surprise that the number of studies which have 
yielded such data are still relatively few. Corresponding calculations for blood pressure 
are shown in Table 3. The respective references are given in these tables [103, 108, 109, 
110, 113, 208-21 I]. The risk ratios are, of course, highly dependent on age and on the 
cutting points used. Space does not permit a detailed discussion but it would seem fair 
to generalize that the gradients are quite steep for both serum cholesterol and blood 
pressure when men in the uppermost and lowest parts of the population distribution 
are compared. Otherwise, however, the gradient tends to be about two-fold as a rough 
approximation, being less for prevalence data which may be subject to differential 
mortality and loss from the sample of sick persons. 
In order to obtain a more striking differential, the combined risk from serum 
cholesterol and blood pressure elevation may be calculated. As an illustration, 
calculations based on unpublished data from the Framingham study, supplied through 
the courtesy of Dr. T. R. DAWBER, may be presented (Table 4) . A risk ratio of 2.9 
is obtained, comparing men high on one or both variables and those not high on either. 
This calculation also shows that two-thirds of the subsequent cases originate from 
TABLE 4. CORONARY HEART DISEASE (CHD) IN MEN AGED 40-59, BASED ON g-YEAR FOLLOW-UP DATA 
FROM FRAMINGHAM STUDY* 
Cholesterol and/or 
blood pressure in 
upper range? 
Cholesterol and 
blood pressure in 
lower range? 
Total 
Number of men developing CHD 
within 8 years 
Number of men not developing 
CHD within 8 years 
Total 
66 32 98 
354 548 902 
420 580 1000 
g-year incidence 16% 5.5% 9.8% 
Risk ratio 1615.5~2.9 
*Calculated from unpublished data supplied through the courtesy of Dr. T. R. DAWBER. Basic data 
have been converted to a denominator of 1000 men. 
tUpper range for serum cholesterol 251 mg % or over; upper range for blood pressure 160 systolic or 
over and/or 95 diastolic or over. Lower range defined by values below these respective cutting points. 
somewhat more than one-third (42 per cent) of the total group at risk. The predictive 
power of these two variables is clearly demonstrated. It is also shown that a very large 
proportion of middle-aged men are in the high risk group. The prevalence of these risk 
factors has also been shown to be high in other studies (Table 5). Depending on age 
and cutting point, roughly one-fifth of middle-aged American men have levels of one 
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coronary heart disease is at least twice as high as the average risk. By using age-specific 
incidence rates from the Framingham study [126] for a life-table type of analysis, one 
can calculate that about 30 out of 100 American men will develop manifest coronary 
heart disease prior to the age of 65. By extrapolating from the data in Table 4, it is 
likely that 20 of these 30 men will have high serum cholesterol or blood pressure levels. 
From the point of view of prevention, these figures speak for themselves. It may be 
added that there is no association [102], except at younger ages [l lo], between serum 
cholesterol and blood pressure levels so that the number of those who will be high on 
both can be calculated approximately from the respective prevalence rates of these two 
variables. 
Obesity 
In general, morbidity and mortality [212] are higher among the overweight than 
those whose weight is ‘normal’, using the term overweight rather than obesity advisedly 
because, in many cases, no allowance has been made for muscle mass or skeletal 
variation. It comes as a surprise, therefore, that some of the major epidemiological 
studies of coronary heart disease have not demonstrated a relationship between this 
condition and something less than gross obesity [102]. This is all the more unexpected 
since high blood pressure and obesity are correlated [102, 1101 and, despite earlier 
evidence to the contrary, there is also a correlation between serum cholesterol levels 
and obesity [l lo]. It is quite probable that this paradox is explained in part by the fact 
that obesity is so common in the United States that a differentiating effect is lost; the 
effect might be more marked in other countries. Yet, it is true that there are countries 
in which obestiy is as common, but coronary disease less frequent, than in the United 
States [213]. 
In a disorder caused by multiple disturbances, the confounding effect of variables is 
so complex and the analysis of their separate contributions so dependent on large 
numbers of cases that it would be well to keep an open mind on the relationship 
between coronary disease and obesity. At this time there is little doubt that obesityper 
se is a less potent risk factor than either serum cholesterol or blood pressure level so 
that control of obesity alone is not likely to make a major dent in the frequency of 
coronary disease. 
Several investigations have demonstrated a relationship between body build- 
‘mesomorphy’-and both serum cholesterol levels and coronary heart disease [214]. 
This attribute must be considered, therefore, as a constitutional rather than environ- 
mentally determined risk factor and serves as an index of susceptibility among those 
in whom attention to environmental predisposing factors may be particularly 
important. 
Smoking 
A relationship between smoking and coronary heart disease has been suspected on 
clinical grounds for many years. Early data from epidemiological studies have failed 
to give definitive support to this suspicion [102]. More recently, however, much 
evidence has accumulated both from mortality data [215-2191 and field studies 
[108, 113, 128, 220, 2211 which leaves no doubt that cigarette smoking and coronary 
disease are associated. There has been some hesitation to ascribed causal significance 
to this association since the mortality differential for coronary disease, as between 
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smokers and non-smokers, is 1.5 to 2-fold, in contrast to the lo-or-more-fold gradient 
for lung cancer. This argument loses some force if it is recalled that the overall risk 
ratio for serum cholesterol and blood pressure is also of a similar order in a number 
of studies (Tables 2 and 3). The need for more data is great. 
In the meantime, it is clear from the combined experience of the Framingham and 
Albany studies [221] that the risk ratio between smokers and non-smokers for myo- 
cardial infarction among men aged 4049 years initially free from coronary disease and 
observed for 6-8 years is 3.5; for death from this disease, the ratio is as high as 6.0. 
The incidence rates from which these ratios were calculated had been adjusted for the 
independent effect of serum cholesterol and blood pressure. The risk ratio between 
smokers and non-smokers for angina pectoris showed no significant trend. Since there 
was a gradient according to the amount smoked, the influence for heavy smoking 
would have been even greater than indicated by these average ratios. Similarly, in 
STAMLER'S experience [113], controlling for blood pressure, serum cholesterol and 
weight, the risk ratio between smokers and non-smokers, based on incidence, varied 
between 2.3 and 5.4-a very appreciable gradient. 
The report on “Smoking and Health” by the Surgeon General’s Advisory Committee 
[222] summarized the data on mortality rates according to the amount smoked, from 
five major, prospective studies, including the one in Framingham. The rates vary by 
age and amount smoked; they are higher for young persons and in those smoking 
more. Among the relatively younger men smoking 20 cigarettes or more, the mortality 
ratio is generally well above two. In another part of the report, mortality ratios from 
several large prospective studies are given, based on 26,223 deaths from all causes; the 
pooled mortality ratio was 1.7 for coronary disease among cigarette smokers [222]. 
Persons who stop smoking have lower rates than those who continue [221, 2221. Pipe 
and cigar smoking seem to carry no excessive risk [222]. 
As in the case of other risk factors, inferences on causality cannot depend on the 
demonstration of association alone. A plausible mechanism must be advanced to 
relate physiological and biochemical consequences of smoking to the disease process. 
Space does not permit speculation on such mechanisms, If smoking contributes to the 
cause of coronary heart disease, the effect is probably not mediated by cholesterol or 
blood pressure since these variables are not consistently associated with smoking 
[223-2251. 
Triglyceride and carbohydrate metabolism 
An association between serum triglyceride levels and coronary heart disease has 
been stressed lately. At the same time, except in a rare form of hyperlipemia, an 
increase in the proportion of carbohydrate at the expense of fat in the diet has been 
shown, somewhat paradoxically, to raise serum triglyceride levels [226,227]. Not only 
diabetes but also diminished glucose tolerance in persons without frank diabetes, 
appears to be associated with coronary heart disease [l lo]. The intermediary meta- 
bolism of carbohydrate and fat are clearly interrelated at several points; in fact, the 
controversy over whether “fat burns in the flame of carbohydrates” took place many 
years ago while, conversely, every livestock breeder knows that carbohydrate can fatten 
animals. It is not yet known where cholesterol and phospholipids might tie into this 
picture although their esterification must certainly involve unsaturated fatty acid 
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metabolism at some point [228]. Perhaps, the observation that chlorophenoxyisobuty- 
rate (Atromid) lowers both serum cholesterol and triglyceride levels [229] will help in 
elucidating these metabolic pathways. In any case, the current interest in triglycerides 
has a rational basis and it would not seem illogical to view the problem in conjunction 
with aspects of carbohydrate metabolism. It would be tempting but still speculative 
to regard the common form of triglyceridemia as a manifestation of impaired glucose 
tolerance. 
There are, at present, no published data on triglyceride levels from epidemiological 
studies if it is implied that, in such studies, cases and ‘controls’ must be derived from 
the same population. This is partly due to the fact that triglycerides must be deter- 
mined in the fasting state which is not easy to accomplish in free-living populations. 
Current information, derived from studies in patients and controls, is at best, 
suggestive, while awaiting a more definitive approach based on epidemiological studies. 
According to the data from ALBRINK’S group [230], 46 per cent of the men with 
coronary disease had elevated cholesterol levels, as compared with 26 per cent in the 
control group; however, 82 per cent of the patients but only 36 per cent of the controls 
had elevated triglyceride levels. Therefore, taking the data at face value, triglycerides 
seem to discriminate better but such calculations are very sensitive to age differences 
in frequency distributions and the choice of the cutting point. CARLSON [231] has 
found that triglycerides discriminate better than cholesterol between ydunger patients 
with coronary disease and controls, but the reverse effect was noted among older 
patients; this is perhaps, not surprising since his data show a decrease in triglycerides 
with age among patients whereas in both ALBRINK’S and SCHAEFER’S [232] studies, 
triglycerides normally increase with age. Similar findings on the relationship between 
coronary disease and serum triglycerides were reported by others [233, 2341. 
If triglyceride level should ever become established as one of the predictors of 
coronary heart disease, the frequency distribution in the general population would be 
important to know. As already mentioned, about a third of normal men in ALBRINK’S 
series have elevated levels by her definition but, as far as can be extrapolated from the 
published data, only about 15 per cent of SCHAEFER’S normal men and some 10 per 
cent of CARLSON’S normals fell above 5.5 mEq/l. (150 mg/lOO ml or 2.0 m-moles/l.). 
Part of this difference may be related to differences in method. New data will be 
awaited with interest. BROWN and his colleagues have studied triglyceride levels in 
healthy, young persons [235]. 
In general, the correlation between serum cholesterol and triglycerides is not high 
[230, 2321, perhaps of the order of 0.6. The relationship between weight gain and 
serum triglycerides has further bearing on these questions [236, 2371, as does the 
findings of increased insulin antagonism in patients with myocardial infarction [238]. 
Physical activity 
The thought that manual workers have less arteriosclerosis than sedentary in- 
dividuals was expressed many years ago [40]. Better evidence for this impression was 
provided by MORRIS and his colleagues [239, 2401 in their studies on London bus 
drivers and bus conductors, suggesting that myocardial infarction is about twice as 
common among the drivers although the incidence of angina tended to be in the reverse 
direction; drivers, however, were heavier in weight before they became engaged in this 
occupation. An extensive autopsy study by MORRIS and CRAWFORD has indicated that 
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physical activity is less related to atherosclerosis than myocardial scars [78]; therefore, 
exercise may encourage a better collateral circulation rather than protect against 
atherosclerosis as such. 
Following these provoking reports, the problem has been investigated by several 
other groups. Data based on mortality will be considered first. Recognizing that a 
number of studies in the United States have failed to demonstrate a social gradient in 
the frequency of coronary disease as discussed elsewhere [15], BRESLOW and BUELL 
[241] re-examined mortality data in California, controlling for the ‘general mortality 
risk’, and demonstrated that sedentary workers showed a 40 per cent greater mortality 
from arteriosclerotic heart disease than heavy workers. Similarly, postal clerks have 
a mortality about 1.4 to 1.9 times as high as mail carriers in Washington, D.C. [242]. 
Among U.S. railroad workers, age-adjusted death rates from arteriosclerotic heart 
disease are 5.7 per 1000 for clerks, 3.9 for switchmen and 2.8 for section men [243]. 
With regard to field studies, the incidence of coronary heart disease was 1.7 times 
higher in non-farmers than farmers, as observed in North Dakota [128]. In the study 
in Evans County, Georgia, the overall prevalence of coronary heart disease did not 
differ among white farmers and non-farmers; however, there was a six-fold gradient 
in prevalence between farmers who did none of their own farm work as compared to 
those who did only farm work [109]; these differences were only partly explained in 
terms of serum cholesterol and blood pressure levels. 
In summary, therefore, the evidence is in accordance with the hypothesis that 
physical activity and coronary heart disease are inversely related. This relationship 
has been demonstrated in groups which clearly differ in occupational activity; such 
groups are not easily found in an increasingly mechanized society. In view of the 
troublesome problem of pre-selection, ultimate proof that exercise protects against 
coronary disease requires a field trial in which participants are randomly assigned to 
exercise and non- exercise groups and observed over time; a study of this kind would 
obviously not be easy to conduct. Apart from the reports mentioned, the general topic 
has been reviewed and summarized [224, 2451. 
Social and psychological influences 
Social and psychological factors interact to such a degree that it is impossible and, 
in fact, undesirable, to consider them separately. In the studies to be discussed, social 
indices are used in some and psychological measurements in others but the interpreta- 
tion of the data must take both dimensions into account. 
The social gradient for coronary disease in Britain [246, 2471 is not generally found 
in the United States, as reviewed previously [15]. Nevertheless, urban-farm differences 
have already been mentioned and urbanization of rural areas is accompanied by a rise 
in arteriosclerotic heart disease mortality [248]. In a small rural community of Italian- 
Americans, coronary disease mortality is strikingly low as compared with neighboring 
areas [249]. Men of urban background seem to have a higher incidence of coronary 
disease than men of rural background, regardless of their present residence [250]. 
Occupational and geographic mobility appear to be associated with a higher coronary 
disease incidence and men of European background generally tend to have a lower 
frequency of coronary disease than American-born men [250], with the possible 
exception of men from Ireland [251]. Religion has also been considered in these 
complex relationships [252]. 
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The sex difference for coronary heart disease is usually ascribed to hormonal factors 
but the possibility exists that differences in the mode of life between men and women 
contribute to this phenomenon. The differences in mortality between married, 
widowed, single, and divorced women give some circumstantial support to this notion 
[253-2561. In another study, deaths from coronary disease were more common among 
married than single persons [257]. General physicians are said to be more prone to 
coronary disease than specialists [258]. 
The finding among the employees of the DuPont Company that executives have half 
the incidence of myocardial infarction than men in the lowest salary class is intensely 
interesting and cannot be explained in terms of differences in serum cholesterol, blood 
pressure, smoking or weight levels [259]. Of equal interest is the observation that 
executives who rose through the ranks have higher rates for coronary disease than those 
who did not [260]. 
Several investigators have noted differences in personality characteristics between 
men with and without coronary disease as reviewed elsewhere [ 151; such associations 
are not necessarily causal, as has been pointed out [261]. There is a great need for good 
methods to assess personality and to measure ‘stress’. The physiological and bio- 
chemical consequences of ‘stress’ may be more practical to measure than the provoking 
psychological factors [97]. 
Working long hours may be associated with excessive mortality from coronary 
disease [262]. In a retrospective study of mortality in younger men, no evidence was 
found for an excess of deaths among ‘driving’ individuals [263]; the problem of 
assessing such characteristics is clear. In a series of reports, ROSENMAN and FRIEDMAN 
have described a personality pattern which they consider characteristic of the coronary- 
prone individual and have found it associated with some known predisposing factors 
[264]; it is claimed that the personality pattern in question predicts coronary heart 
disease more effectively than serum lipid and blood pressure measurements [130]. 
These preliminary data await detailed analysis after a more extended period of 
observation. An increase of serum cholesterol levels under stressful circumstances has 
been shown in several [265-2691 but not all [270] studies. 
An attempt has been made to show that social and psychological influences may well 
play a role in the genesis of coronary heart disease but the relative importance of these 
influences as compared with others, their interactions and the effective pathways remain 
to be explored. Considerable work along these lines is underway; some more general 
discussions have been published [271-2761. 
Genetic factors 
There is presumably no illness in which genetic predisposition plays no part and 
atherosclerosis and coronary heart disease are certainly no exceptions. Three predis- 
posing factors in particular-serum cholesterol, blood pressure and blood sugar levels 
-are partly under genetic control so that familial aggregations of coronary heart 
disease can be anticipated to exist. Such aggregations are likely to have both genetic 
and environmental determinants since families share their environment as well as 
their genes. Hereditary factors in coronary heart disease have recently been reviewed 
in considerable detail [277] and a summary of data on genetics and atherosclerosis has 
been given elsewhere [278]. 
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For the purpose of this review on epidemiology, it must be stated that epidemio- 
logical studies as such have, so far, contributed little to this field although epidemiology 
is, in one sense, the study of the transactions between environmental and genetic factors. 
Familial data, based on the examination of relatives, have generally not been a part of 
epidemiological studies of coronary heart disease, in contrast to epidemiological studies 
of some of the predisposing factors. The methodological and logistic problems in such 
studies are very considerable [279] and account, in part, for the fact, that so few have 
been done. The epidemiological studies by THOMAS in Baltimore [280] and in 
Tecumseh, Michigan, have a strong focus on observations within families [281, 2821. 
Progress in this area will depend on further studies of coronary heart disease and 
predisposing factors in relatives of propositi and suitable control groups. 
Other risk factors 
It is unfortunate that, for reasons of space, this section must be short and lacking in 
detail since under this overall heading there will no doubt be hidden several hitherto 
unexplored or unknown risk factors. One reasons why extensive accounts of the 
influences discussed earlier could be given is that more research has been done in these 
particular areas. In other areas, epidemiological studies have been hampered by lack 
of methods sufficiently reliable and simple enough to be applied to field studies. This 
is particularly true in connection with the factors involved in thrombosis, blood 
coagulation and fibrinolysis [283]. What may matter with regard to these factors might 
not be their static levels, if such exist, but their dynamic changes which are difficult to 
ascertain in population studies; nevertheless onetime measurements of platelet 
adhesiveness would seem very worthwhile [284]. 
The influence of hormones on atherogenesis is of great epidemiological relevance. 
The sex differences in the frequency of coronary heart disease are certainly due, in 
large part, to hormonal factors. Inter-individual differences in lipid levels are probably 
determined partly by hormonal patterns, as are the fluctuations in level in the same 
person under various environmental stresses. Hormones have also been shown to 
affect the metabolism of the arterial wall. It is likely that a number of epidemiological 
phenomena relating to differences in disease frequency between various population 
groups are mediated in some fashion by hormonal interactions. Gonadal, adrenal, 
thyroid and pituitary hormones have all been studied in relation to atherogenesis in 
experimental animals; methodological difficulties have limited the assessment of 
hormonal factors in man, particularly in epidemiological surveys. Several investiga- 
tions have, however, suggested that hormonal therapy may influence the course of 
coronary heart disease in human beings. A number of reviews on these complex 
hormonal interrelationships in atherosclerosis are available [285-2871. Finally, 
differences in reproductive performance among women with and without coronary 
heart disease suggest not only that affected women have distinctive hormonal patterns 
but that these patterns may contribute to the genetic make-up of the population [288]. 
More generally, any factor involved in atherogenesis is of obvious relevance to the 
epidemiologist. It is an urgent task to bring these experimental and clinical leads and 
suggestions within the realm of epidemiological testing and, conversely, to test in the 
clinical and experimental setting some epidemiological observations. Among these, the 
interesting inverse relationship between water hardness and coronary heart disease 
mortality comes to mind [289, 2901; a comprehensive analysis of other causes of 
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mortality andiwater hardness [291] has revealed that such a relationship is not confined 
to coronary disease so that the problem of ‘causation versus association’ is raised once 
more. 
Among clinical-epidemiological interrelationships, there is a need to assess the 
significance of so-called ‘non-specific’ electrocardiographic changes. It would appear 
that most of these, at least in Western countries, are associated with myocardial disease 
of atherosclerotic origin. Yet, the electrophysiology of these alterations which can 
also be evoked by functional disturbances [292], is still poorly understood. Several 
studies, as summarized by UNGERLEIDER [ 1111, suggest that persons with such changes 
are more prone to develop frank coronary heart disease than those with ‘normal’ 
electrocardiograms. The line analysis of the QRS complex in terms of the first deriva- 
tive of the electrocardiogram also deserves epidemioIogica1 study because of its poten- 
tial as a valuable predictor [293]. 
Multiple risk factors 
If single risk factors have predictive value, as has been shown, simultaneous evalua- 
tion of multiple risk factors should enhance predictive power; this has already been 
discussed with regard to serum cholesterol and blood pressure levels. Data on 
combined risk, based on serum cholesterol levels, blood pressure levels, smoking and 
weight, have been reported by several groups at various meetings but are still largely 
unavailable. Such data have, however, been published from the Framingham study and 
are likely to be quite representative [126]. Taking cholesterol, blood pressure and 
smoking as risk factors, the morbidity ratio of 45 for myocardial infarction when none 
of the three factors are high, rises stepwise to 563 when all three are high; it is note- 
worthy that only 49 per cent of all the men aged 30-59 initially at risk were not high 
on all three factors while 5 1 per cent were high on one or more. On dividing cholesterol 
and blood pressure levels into three ranges and adding the presence or absence of left 
ventricular hypertrophy on the electrocardiogram, among men aged 4049 in 
Framingham, only 9 per cent of the population is ‘low’ on all three variables; the 
morbidity ratio of 16 for all forms of coronary disease among these men rises to no 
less than 261 among the 8 per cent of the men who are ‘high’ on two of these three 
factors. It is quite obvious that not all men in the United States are prone to coronary 
heart disease though they represent a regrettably small minority. 
Other data from the Los Angeles study [210], to quote one example from this study, 
show that the incidence of coronary heart disease is 2.5 times higher when blood 
pressure and cholesterol are elevated than when both are in the lower range. Since 
there are interactions between the variables, some of these calculations are very 
difficult and discriminant function analysis has been applied to this problem [294]. 
Further data, based on prevalence, from the Evans County study [109] indicate that 
white men who rank ‘high’ on cholesterol, blood pressure and social class manifest 
coronary disease almost ten times as often as men who are ‘low’ on all three variables. 
Comparing men whose serum cholesterol and blood pressure are low with men high 
on both, weight and smoking held constant, STAMLER finds a 7- to 9-fold difference in 
incidence between these two groups; only 209 of the 1329 men (16 per cent) fell into 
the ‘low’ group [ 1131. Related data have been discussed by STAMLER elsewhere [295]. 
Further information on the predictive value of risk factors in combination comes from 
the study of PAUL and his colleagues, already mentioned [108], based on hitherto 
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unpublished six-year follow-up data [296]. In that study among employed men, 
cigarette smoking and coffee intake were both independently related to the incidence of 
coronary heart disease as were serum cholesterol and blood pressure levels. On 
comparing incidence rates when serum cholesterol, cigarette smoking and coffee 
drinking were all ‘high’ with the rates when all three were ‘low’, an almost 5-fold 
difference was found; a similar gradient was observed when the analysis was repeated, 
substituting blood pressure for serum cholesterol. Incidence was 4.1 times greater 
when blood pressure, serum cholesterol and cigarette smoking were all ‘high’ as com- 
pared with all three being ‘low’. Another three-way analysis, based so far on prevalence 
data, was done as part of the Tecumseh Community Health Study [281, 2821, using as 
the variables, serum cholesterol, blood pressure and blood glucose levels, the latter 
being determined one hour after a standard load. When all three variables were in the 
upper range (i.e. above the age and sex-specific 80th percentile point), the ‘relative 
prevalence’ was 5.5 times higher among men and 6.2 times higher among women, in 
comparison with the rates when all three variables were below the 80th percentile [297]. 
Such data dispel the notion that little is known about the precursors of clinical 
coronary heart disease. The predictive power of the combination of these multiple 
risk factors is clearly striking. At the same time, it is apparent that the prevalence of 
these factors singly and particularly in combination is so great that a major proportion 
of the population is at risk because of one or more of them. It is not possible, therefore, 
in terms of these particular variables, to identify a minority of ‘susceptibles’ among 
whom the majority of clinical events will occur. Perhaps, this is in the nature of the 
disease but, as likely, more discriminating risk factors remain to be identified. 
PREVENTION 
‘Prevention’ in relation to coronary heart disease must be taken to mean that 
premature onset of the disease should be prevented; death from a heart attack at an 
advanced age would not seem necessarily undesirable. The early toll from the disease 
has already been stressed. The need for prevention in the above sense is emphasized 
by the fact that the mortality from acute heart attacks is underestimated from hospital 
statistics since many victims never reach the hospital. In the Framingham experience 
[298] which takes account of this factor, 34 per cent of all the middle-aged men who 
developed ‘heart attacks’ died within three weeks of the onset and 56 per cent of those 
who died survived their attack for less than one hour; the immediate risk of dying was 
highly related to initial serum cholesterol level but not, in this case, to high blood 
pressure. These figures highlight the need to prevent the attack from occurring in the 
first instance. 
Since none of the risk factors discussed have been ‘proven’ to be causally related to 
coronary heart disease, only circumstantial reasoning would permit the inference that 
control of these risk factors would reduce disease incidence. The circumstantial 
evidence is, however, strong that reduction of blood pressure and serum cholesterol 
levels, avoidance of at least excessive smoking of cigarettes, maintenance of adequate 
physical activity and of reasonable weight would be effective preventive measures. 
Regarding control of these predisposing factors, all but the first are dependent to a 
greater or lesser degree on a decision, however hard it may to be make it, on the part of 
the individual. Elevated blood pressure cannot be controlled, as far as it is known 
today, by environmental means since the environmental determinants of blood pressure 
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are inadequately known; the possible importance of salt intake in this connection has 
been discussed elsewhere [198]. Since some 20 per cent of middle-aged men in this 
country have frankly elevated blood pressures, it may at least be questioned whether 
as much as one-fifth of this population should use anti-hypertensive drugs prophylac- 
tically, considering that most drugs are necessarily ‘toxic’ to some extent; the problem 
is to balance the risk of toxicity against the risk of premature coronary heart disease, 
or, for that matter, strokes. There remains the problem of serum cholesterol levels to 
which the remainder of this discussion will be confined. 
It may be calculated [299] that a reduction of serum cholesterol level of about 15 per 
cent among American middle-aged men, taking the competing effect of blood pressure 
into account, might lower the incidence of coronary heart disease by about 35 per 
cent. While this figure cannot be more than an intelligent guess on the basis of current 
data, the possibility of making a dent of this, admittedly not optimal, magnitude by in- 
tervening on one of the several risk factors alone must be considered most earnestly 
from a public health point of view. There is reason to think, if only circumstantially, 
that a lowering of serum cholesterol level, even without intervening on the blood 
pressure factor directly, might benefit those in whom blood pressure is raised. Data 
from the Framingham study indicate that the incidence of coronary heart disease 
among hypertensives is rather less than half as high when serum cholesterol level is, 
say, 200 mg/lOO ml than at levels of 250 mg/lOO ml [126]. 
It has been known for some years that serum cholesterol levels, under closely 
supervised conditions, can be lowered by reducing the amount of saturated fat in the 
diet [300-3021. Whether or not a simultaneous increase in the amount of polyunsatur- 
ated fatty acids will further enhance this effect is not entirely certain. In any case, 
moderate amounts of fat in the diet, supplied by partially substituting unsaturated for 
saturated fats, will make the diet more palatable for the average person in this country 
and will prevent a possible increase in serum triglycerides which may occur on a low 
fat diet and, for the reasons mentioned before, might be undesirable. With regard to 
the interrelations between carbohydrate and lipid metabolism discussed earlier, 
attention to weight control through avoidance of excessive carbohydrate intake might, 
in addition, have a favorable effect on the aspects of atherogenesis related to impaired 
glucose tolerance. 
There is no good evidence that diets in which about 30 per cent of the calories come 
from fat, with about equal amounts being derived from saturated, mono-unsaturated 
and polyunsaturated fatty acids, might be atherogenic. It must be admitted that diets 
high in polyunsaturated fatty acids can cause arterial lesions in rats even though serum 
cholesterol is reduced [303]. Furthermore, the critical issue whether a fall in serum 
cholesterol with a diet high in polyunsaturated fats is accompanied by increased sterol 
excretion has not been settled. This matter has been studied in man by several investi- 
gators but no consensus has been reached. If sterol excretion remains constant in the 
face of a decrease in serum cholesterol while the diet is changed from one high in 
saturated fats to one high in polyunsaturated fats, as has been reported [304], it must 
be inferred that cholesterol shifts from the serum into the tissues under these circum- 
stances. 
Several studies involving prospective observations among volunteers, institutional 
groups and high-risk individuals on such modified fat diets are now underway 
[305-3071. Preliminary results from one of these groups suggest a strikingly low 
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incidence of coronary heart disease among these volunteers [306]. In addition, a 
national pilot study on the feasibility of a definitive, active prophylactic trial concerning 
the effect of such diets on the incidence of coronary heart disease is in progress [308]. 
The experience gained in these several studies leaves no reasonable doubt that free- 
living individuals will adhere to fat-modified meals and that an average serum- 
cholesterol lowering of about 15 per cent of the control value (e.g. a reduction from an 
average of 235 mg/lOO ml to 200 mg/lOO ml) can usually be achieved. The stage is, 
therefore, well set for a serious attempt toward dietary control of coronary heart disease 
as, at least, one measure which may aid in the prevention of this condition. Among the 
many publications on this subject, a number will serve to document further these 
summary remarks [309-3121. 
A series of investigations have suggested that serum cholesterol and dietary fat intake 
are not correlated in Western countries [ 108, 3 13-3 151. This is hardly surprising since 
almost everyone in these countries is consuming a diet which is high in total and satur- 
ated fat. This is well illustrated in the study by PAUL and his associates who found no 
difference in coronary disease incidence among men in the highest and lowest quintile 
of fat intake [108]; however, even the men in the lowest quintile consumed 36 per cent 
of their calories as fat and their average serum cholesterol level was as high as 247 
mg/lOO ml so that, as the authors indicate, minor alterations in the so-called ‘average’ 
American diet are not likely to achieve the desired goal. At the same time, the experi- 
ences already quoted [305-3081 do not suggest that these alterations must be so drastic 
as to be unacceptable. 
SUMMARY AND RECOMMENDATIONS 
The burden and trend of mortality from coronary heart disease in the United States 
and other countries have been defined on the basis of mortality statistics and patho- 
logical studies. Data on morbidity in terms of prevalence and incidence rates in 
different populations were reviewed and correlated with a series of associated risk 
factors. Possible means of preventing coronary heart disease were discussed. The 
cumulative evidence strongly suggests that environmental influences are largely 
responsible for making coronary heart disease a major public health problem in many 
countries. 
In order to turn suggestive evidence into greater certainty, more research is required. 
While remarkable strides have been made in recent years, further progress depends not 
only on more studies but on methodological improvements. One prerequisite is the use 
of methods which will make it possible to be certain that the observed differences and 
similarities between population groups are real and to assess the relative contributions 
of risk factors which may account for these findings. Another prerequisite is the 
development of more valid, sensitive and reliable methods for disease detection and, 
particularly, detection of early, pre-clinical deviation from health. The same need 
applies to a more precise definition of known risk factors and the discovery of hitherto 
unrecognized risk factors, in order to detect susceptibility to coronary heart disease at 
younger ages. 
For the study of susceptibility, more emphasis should be given to observations among 
younger persons and familial interrelationships in order to separate environmental 
factors from genetic predisposition. Such knowledge will make it eventually possible to 
institute preventive measures early in life among those most highly at risk. 
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In the meantime, an attempt was made to show that epidemiological research in the 
past decade made significant inroads into the problem of predicting coronary heart 
disease and that some of these discoveries are ready to be put to the test in experimental 
coronary disease prevention programs. 
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